Ameripath

Chrysalis’ investment was in American Pathology Resources, a Nashville, TN-based physician management company focusing on pathology practices. American Pathology merged with Pathology Consultants of America, which was subsequently purchased by Inform DX before being acquired by AmeriPath (Former NASAQ: PATH) in November 2000. Today the company is a provider of cancer diagnostics, genomics and related information services.